Although CPT II deficiency and very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency have similar clinical phenotypes, research articles focusing on NBS for CPT II deficiency are apparently far fewer than those for VLCAD. This evidence concerns the gene CPT2 and very long chain acyl-CoA dehydrogenase deficiency.